Team explores diabetes drug’s ability to treat RSV infection

Posted on July 10, 2018 by Gastroenterology Journal

MyVUMC PhotoA multi-disciplinary team of Vanderbilt investigators has demonstrated that a drug used to treat type 2 diabetes reduces the inflammatory response to RSV infection.


This entry was posted in News. Bookmark the permalink.